Literature DB >> 22179322

Giant cell tumor of the mobile spine: a review of 49 cases.

Stefano Boriani1, Stefano Bandiera, Roberto Casadei, Luca Boriani, Rakesh Donthineni, Alessandro Gasbarrini, Elettra Pignotti, Roberto Biagini, Joseph H Schwab.   

Abstract

STUDY
DESIGN: This is a retrospective review of 49 cases of giant cell tumor (GCT) of the mobile spine treated surgically.
OBJECTIVE: Our goal was to determine which factors influenced local recurrence. SUMMARY OF BACKGROUND DATA: GCT is a benign, locally aggressive tumor that rarely occurs in the spine. The management of local recurrence can be challenging.
METHODS: We performed a retrospective analysis of GCTs of the mobile spine managed between 1970 and 2005. Median follow-up was 145 months with a minimum of 2 years or until death. We used the Kaplan-Meier method to test whether Enneking stage, surgery type, and surgical margin had statistically significant impact on local recurrence. The log rank test was used for comparison, and a P value of less than 0.05 was deemed significant.
RESULTS: Of the 49 patients, 11 (22%) local recurrences occurred. The latest recurrence occurred at 60 months. Age less than 25 years was associated with a worse relapse-free survival (P = 0.03). En bloc resection was associated with better local control with Enneking stage III tumors (P = 0.01); however, intralesional resection provided adequate control of Enneking stage II tumors. There were 6 (12%) cases of metastasis, and 2 patients died from the progression of their disease. One patient died from the complications of the surgery.
CONCLUSION: En bloc resection should be considered for Enneking stage III GCTs of the mobile spine. The choice of en bloc resection must be balanced with the inherent risks of the procedure. Intralesional resection of Enneking stage II tumors provides adequate local control. Patients should be followed for at least 5 years because local relapse can occur late.

Entities:  

Mesh:

Year:  2012        PMID: 22179322     DOI: 10.1097/BRS.0b013e3182233ccd

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  50 in total

Review 1.  Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.

Authors:  Stefano Boriani; Riccardo Cecchinato; Fabrizio Cuzzocrea; Stefano Bandiera; Marco Gambarotti; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2019-05-16       Impact factor: 3.134

2.  Surgeon's perception of margins in spinal en bloc resection surgeries: how reliable is it?

Authors:  Ran Lador; Alessandro Gasbarrini; Marco Gambarotti; Stefano Bandiera; Riccardo Ghermandi; Stefano Boriani
Journal:  Eur Spine J       Date:  2017-02-06       Impact factor: 3.134

3.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

4.  Neck pain in a 27-year-old man.

Authors:  Addisu Mesfin; Jacob M Buchowski; Mitra Mehrad; Jianwen Xu
Journal:  Clin Orthop Relat Res       Date:  2013-02-15       Impact factor: 4.176

Review 5.  Tumors of the spine.

Authors:  Mert Ciftdemir; Murat Kaya; Esref Selcuk; Erol Yalniz
Journal:  World J Orthop       Date:  2016-02-18

6.  Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.

Authors:  K Zhang; M Zhou; H Chen; G Wu; K Chen; H Yang
Journal:  Clin Transl Oncol       Date:  2015-03-05       Impact factor: 3.405

7.  Differentiation of spinal giant cell tumors from chordomas by using a scoring system.

Authors:  Takashi Tsuji; Kazuhiro Chiba; Kota Watanabe; Ken Ishii; Masaya Nakamura; Yuji Nishiwaki; Morio Matsumoto
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-07-22

8.  Predictors for surgical complications of en bloc resections in the spine: review of 220 cases treated by the same team.

Authors:  Stefano Boriani; Alessandro Gasbarrini; Stefano Bandiera; Riccardo Ghermandi; Ran Lador
Journal:  Eur Spine J       Date:  2016-03-14       Impact factor: 3.134

9.  Morbidity of en bloc resections in the spine.

Authors:  Stefano Boriani; Stefano Bandiera; Rakesh Donthineni; Luca Amendola; Michele Cappuccio; Federico De Iure; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2009-08-19       Impact factor: 3.134

10.  A thoracic spinal bone giant cell tumor in a skeletally immature girl. A case report and literature review.

Authors:  Loic Sigwalt; Emeline Bourgeois; Ahmad Eid; Chantal Durand; Jacques Griffet; Aurélien Courvoisier
Journal:  Childs Nerv Syst       Date:  2016-01-05       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.